| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ADAPTIMMUNE THERAPEUTICS PLC | 566,368 | 2,294,000 | 0.10% | ||
| 102 | ENDOLOGIX INC | 386,750 | 2,212,000 | 0.09% | ||
| 103 | ACADIA COMPANY COM | 64,900 | 2,148,000 | 0.09% | ||
| 104 | ADAMAS PHARMACEUTICALS INC | 125,504 | 2,121,000 | 0.09% | ||
| 105 | MCKESSON CORP | 15,000 | 2,107,000 | 0.09% | ||
| 106 | ADR - Nabriva Therapeutics AG- Usd | 350,000 | 2,083,000 | 0.09% | ||
| 107 | AMICUS THERAPEUTICS INC COM | 418,730 | 2,081,000 | 0.09% | ||
| 108 | HEALTHCARE RLTY TR | 68,000 | 2,062,000 | 0.09% | ||
| 109 | FORWARD PHARMA A/S | 136,547 | 2,050,000 | 0.09% | ||
| 110 | HALOZYME THERAPEUTICS INC | 200,000 | 1,976,000 | 0.08% | ||
| 111 | ACHILLION PHARMACEUTICALS IN | 443,851 | 1,833,000 | 0.08% | ||
| 112 | ALLSCRIPTS HEALTHCARE SOLUTN | 173,600 | 1,772,000 | 0.08% | ||
| 113 | IMPAX LABORATORIES INC | 124,335 | 1,647,000 | 0.07% | ||
| 114 | DIPLOMAT PHARMACY INC COM | 130,223 | 1,641,000 | 0.07% | ||
| 115 | WELLTOWER INC | 21,400 | 1,432,000 | 0.06% | ||
| 116 | CHIMERIX INC | 308,892 | 1,421,000 | 0.06% | ||
| 117 | ACCELERON PHARMA INC | 54,450 | 1,390,000 | 0.06% | ||
| 118 | CIDARA THERAPEUTICS INC | 132,472 | 1,378,000 | 0.06% | ||
| 119 | DYNAVAX TECHNOLOGIES CORP | 345,050 | 1,363,000 | 0.06% | ||
| 120 | HCP INC | 45,500 | 1,352,000 | 0.06% | ||
| 121 | UNIQURE NV | 241,021 | 1,350,000 | 0.06% | ||
| 122 | HEALTHCARE TR AMER INC | 46,000 | 1,339,000 | 0.06% | ||
| 123 | Esperion Therapeutics Inc | 102,800 | 1,287,000 | 0.05% | ||
| 124 | SPARK THERAPEUTICS INCORPORATED | 24,300 | 1,213,000 | 0.05% | ||
| 125 | GENMARK DIAGNOSTICS INC. | 93,349 | 1,143,000 | 0.05% | ||
| 126 | COMMUNITY HEALTH SYS INC NEW | 203,935 | 1,140,000 | 0.05% | ||
| 127 | THERAPEUTICSMD INC | 187,100 | 1,080,000 | 0.05% | ||
| 128 | JUNO THERAPEUTICS INC COM | 56,900 | 1,073,000 | 0.05% | ||
| 129 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 974,000 | 0.04% | ||
| 130 | INTELLIA THERAPEUTICS INC | 71,842 | 942,000 | 0.04% | ||
| 131 | FLEX PHARMA INC COM | 162,124 | 856,000 | 0.04% | ||
| 132 | AURIS MED HLDG AG | 774,504 | 829,000 | 0.04% | ||
| 133 | BELLICUM PHARMACEUTICALS INCORPORATED | 60,000 | 817,000 | 0.03% | ||
| 134 | TETRAPHASE PHARMACEUTICALS INC COM | 192,322 | 775,000 | 0.03% | ||
| 135 | NOVAVAX INC COM | 571,000 | 719,000 | 0.03% | ||
| 136 | GLOBAL MED REIT INC COM NEW | 73,400 | 655,000 | 0.03% | ||
| 137 | AFFIMED N V COM | 294,213 | 530,000 | 0.02% | ||
| 138 | XENCOR INC COM | 20,000 | 526,000 | 0.02% | ||
| 139 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 375,000 | 0.02% | ||
| 140 | RMR GROUP INC | 7,441 | 294,000 | 0.01% | ||
| 141 | QUORUM HEALTH CORP | 23,725 | 172,000 | 0.01% | ||
| 142 | ZAFGEN INC COM | 13,307 | 42,000 | 0.00% | ||
| 143 | ABBVIE INC | 156 | 10,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-17-008451, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
